We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Dlouhodobá účinnost a bezpečnost siponimodu u pacientů se sekundárně progresivní roztroušenou sklerózou: analýza základních dat studie EXPAND a její extenze.
- Authors
Pavelek, Zbyšek; Vališ, Martin
- Abstract
Siponimod significantly reduced the risk of confirmed disability progression, worsening in cognitive processing speed, relapses, and magnetic resonance imaging measures of brain atrophy and inflammation in secondary progressive multiple sclerosis patients. Data from the 5-year extension of the EXPAND study support the importance of early detection of secondary progressive multiple sclerosis and thus early initiation of siponimod treatment.
- Subjects
COGNITIVE processing speed; MAGNETIC resonance imaging; CEREBRAL atrophy; MULTIPLE sclerosis; ENCEPHALITIS
- Publication
Neurologie Pro Praxi, 2023, Vol 24, Issue 3, p206
- ISSN
1213-1814
- Publication type
Article
- DOI
10.36290/neu.2023.005